Apellis Pharmaceuticals I... (APLS)
NASDAQ: APLS
· Real-Time Price · USD
27.77
0.15 (0.54%)
At close: Aug 15, 2025, 3:59 PM
27.61
-0.55%
After-hours: Aug 15, 2025, 07:52 PM EDT
Apellis Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 371.47M | 358.39M | 411.29M | 396.86M | 361.43M | 327.03M | 352.3M | 452.41M | 616.26M | 765.08M | 551.8M | 584.19M | 604.49M | 633.46M | 640.19M | 283.75M | 270.76M | 265.44M |
Short-Term Investments | n/a | n/a | n/a | n/a | 7.95M | 7.62M | 4.35M | 13.12M | 9.42M | 9.04M | 6.5M | 124.36M | 248.31M | 331.84M | 60.36M | 146.57M | 328.25M | 458.24M |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 49.03M | 61.8M | 77.06M | 47.53M | 24.35M | 1.31M | 1.31M | 1.18M | 827K | 793K | 15.8M | 15.75M | 15.88M | 16.01M | 31.64M | 22.82M | 16.1M | 6.91M |
Receivables | 229.23M | 244.38M | 271.72M | 283.97M | 308.85M | 267.84M | 206.44M | 186.99M | 128.3M | 31.5M | 7.73M | 8.09M | 7.52M | 6.33M | 10.1M | 3.52M | 719K | 20M |
Inventory | 121M | 82.47M | 81.4M | 121.06M | 152.77M | 161.28M | 146.36M | 98.55M | 103.22M | 85.48M | 85.71M | 59.75M | 48.45M | 32.85M | 16.29M | 1.68M | 3.73M | n/a |
Other Current Assets | 4.75M | 5.38M | 6.17M | 8.2M | 7.95M | 12.12M | 22.41M | 14.2M | 10.51M | 35.62M | 36.66M | 25.18M | 29.73M | 74.97M | 72.24M | 22.54M | 32.8M | 26.85M |
Total Current Assets | 755.61M | 727.72M | 788.95M | 833.9M | 859.97M | 811.43M | 766.33M | 796.77M | 892.69M | 954.25M | 719.52M | 831.94M | 959.97M | 1.1B | 824.05M | 475.43M | 655.13M | 773.63M |
Property-Plant & Equipment | 16.75M | 17.77M | 19.04M | 20.44M | 20.16M | 19.19M | 21.09M | 20.27M | 22.07M | 23.82M | 24.89M | 25.2M | 26.65M | 25.86M | 26.08M | 27.44M | 28.69M | 29.59M |
Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 65.78M | 79.57M | 96.1M | 67.97M | 44.51M | 20.5M | 22.4M | 21.45M | 22.89M | 24.61M | 40.69M | 40.95M | 42.53M | 41.87M | 57.72M | 50.26M | 44.79M | 36.5M |
Total Assets | 821.39M | 807.28M | 885.05M | 901.87M | 904.48M | 831.93M | 788.73M | 818.22M | 915.58M | 978.87M | 760.22M | 872.89M | 1B | 1.15B | 881.76M | 525.69M | 699.91M | 810.13M |
Account Payables | 54.24M | 55.29M | 38.57M | 42.73M | 38.27M | 26.79M | 37.52M | 18.19M | 27.5M | 31.49M | 37.34M | 14.1M | 16.22M | 12.27M | 16.91M | 4.98M | 5.34M | 4.16M |
Deferred Revenue | n/a | n/a | n/a | 1.9M | 1.9M | 3.56M | n/a | 117.09M | 97.72M | n/a | n/a | n/a | n/a | n/a | 103.24M | 69.85M | 134.3M | 69.4M |
Short-Term Debt | 7.42M | n/a | n/a | 6.79M | 6.21M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 112.53M | 38.9M | 99.3M | 98.32M | 87.37M | 77.29M | 151.85M | 44.61M | 43.77M | 30.07M | 81.43M | 16.15M | 15.84M | 2.66M | 7.58M | 15.33M | 14.11M | 6.21M |
Total Current Liabilities | 200.66M | 178.38M | 185.51M | 191.26M | 169.17M | 215.29M | 247.59M | 185.63M | 174.84M | 138.64M | 167.61M | 115.45M | 126.79M | 124.77M | 131.85M | 94.24M | 157.79M | 83.67M |
Long-Term Debt | 454.04M | 453.42M | 452.83M | 452.25M | 457.21M | 337.54M | 93.03M | 92.96M | 92.88M | 92.81M | 92.74M | 92.66M | 189.31M | 189.17M | 189.02M | 189.61M | 386.47M | 386.15M |
Other Long-Term Liabilities | 2.08M | 2.08M | 7.97M | 9.83M | 2.69M | 2.66M | 242.13M | 296.48M | 290.39M | 322.06M | 315.65M | 342.08M | 335.3M | 352.99M | 345.15M | 281.02M | 278.02M | 268.74M |
Total Long-Term Liabilities | 464.43M | 464.69M | 471M | 473.49M | 470.99M | 349.96M | 346.62M | 400.31M | 395.34M | 428.1M | 422.74M | 450.03M | 541.29M | 558.85M | 551.26M | 488.78M | 683.62M | 674.8M |
Total Liabilities | 665.09M | 643.07M | 656.51M | 664.75M | 640.15M | 565.25M | 594.21M | 585.95M | 570.17M | 566.75M | 590.35M | 565.48M | 668.08M | 683.62M | 683.1M | 583.01M | 841.4M | 758.47M |
Total Debt | 469.77M | 469.55M | 469.78M | 470.45M | 474.51M | 430.85M | 110.93M | 109.58M | 110.8M | 111.87M | 112.71M | 113.37M | 211.3M | 210.42M | 210.22M | 211.83M | 409.63M | 409.96M |
Common Stock | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 12K | 11K | 11K | 11K | 11K | 10K | 9K | 8K | 8K |
Retained Earnings | -3.17B | -3.13B | -3.04B | -3B | -2.94B | -2.9B | -2.84B | -2.75B | -2.61B | -2.49B | -2.31B | -2.14B | -1.95B | -1.8B | -1.66B | -1.51B | -1.31B | -1.09B |
Comprehensive Income | -2.57M | -3.05M | -3.31M | -3.14M | -3.36M | -3.52M | -3.54M | -1.06M | -796K | -775K | -875K | -3.03M | -3.19M | -2.06M | -2.09M | -2.01M | -1.83M | -1.62M |
Shareholders Equity | 156.31M | 164.22M | 228.54M | 237.12M | 264.33M | 266.68M | 194.52M | 232.27M | 345.4M | 412.12M | 169.87M | 307.42M | 334.42M | 462.24M | 198.66M | -57.33M | -141.49M | 51.66M |
Total Investments | n/a | n/a | n/a | n/a | 7.95M | 7.62M | 4.35M | 13.12M | 9.42M | 9.04M | 6.5M | 124.36M | 248.31M | 331.84M | 60.36M | 146.57M | 328.25M | 458.24M |